🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
1,930

Quick answer

1,930 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 8133902

    Ammosamides as anticancer agents

    The Regents of the University of California · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8114590

    Diagnosis and treatment of chronic lymphocytic leukemia (CLL)

    The Regents of the University of California · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8110352

    Method of diagnosing and treating cancer using B-catenin splice variants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8101740

    Positron emission tomography probes for imaging immune activation and selected cancers

    The Regents of the University of California · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8101159

    In vivo methods of identifying compounds which target suppressed cancer cells

    The Board of Regents of the University of Oklahoma · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8093246

    O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8088749

    Compositions and methods for treating cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8084199

    Method of diagnosing poor survival prognosis colon cancer using microRNA-21

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8075900

    Melanoma associated peptide analogues and vaccines against melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8076352

    Administration of carboline derivatives useful in the treatment of cancer and other diseases

    PTC THERAPEUTICS, INC. · Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8067563

    Tumor suppressor gene, p471NG3

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8058244

    Cyclic peptide antitumor agents

    Northwestern University · Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8053422

    Anti-cancer oligodeoxynucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8048418

    Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8043623

    Immunogenic peptides for the treatment of prostate and breast cancer

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8044033

    Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8044259

    Determining the capability of a test compound to affect solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8030280

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8030012

    Id-1 and Id-2 genes and products as markers of epithelial cancer

    The Regents of the University of California · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8029788

    Variants of humanized anti-carcinoma MAb CC49

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8026350

    Tumor suppressor gene, p28ING5

    The United States of America as represented by theDepartment of Health and Human Services · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8012490

    Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8008266

    Methods of treating cancer using immunostimulatory oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8008316

    Azonafide derived tumor and cancer targeting compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7994306

    Methods of treating cancer using siRNA molecules directed against CD24

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7989501

    Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7981618

    Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer

    The Board of Regents of the University of Texas System · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7981610

    ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7977320

    Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents

    The Regents of the University of California · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7977468

    Chromosome 3p21.3 genes are tumor suppressors

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7968115

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7959923

    Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA

    The Regents of the University of California · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7955602

    Annexin proteins and autoantibodies as serum markers for cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7951356

    Tissue factor compositions and kits for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7943318

    Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7939263

    Compositions and methods for treating and diagnosing cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7939635

    Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7919466

    Lymphatic zip codes in tumors and pre-malignant lesions

    The Regents of the University of California · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7919079

    Cancer immunotherapy compositions and methods of use

    The Regents of the University of California · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7919246

    SEMA4D in cancer diagnosis, detection and treatment

    Sagres Discovery, Inc. · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7914780

    Aminopeptidase A (APA) targeting peptides for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7902441

    Chromosome 3p21.3 genes are tumor suppressors

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7897340

    Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker

    The Board of Regents of the University of Texas System · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7897355

    Gene expressed in prostate cancer and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7893299

    Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators

    The Regents of the University of California · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7892730

    Compositions and methods for cancer

    Sagres Discovery, Inc. · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7887836

    Compositions and methods for treating lymphoma

    The Board of Regents of the University of Texas System · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7871775

    Compositions and methods for the identification, assessment, prevention and therapy of human cancers

    The Board of Regents of the University of Texas System · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Oncology patents are indexed?

1,930 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.